ALIGNMENT HEALTHCARE INC (ALHC)

US01625V1044 - Common Stock

6.92  +0.71 (+11.43%)

After market: 6.59 -0.33 (-4.77%)

Fundamental Rating

2

ALHC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 117 industry peers in the Health Care Providers & Services industry. ALHC has a bad profitability rating. Also its financial health evaluation is rather negative. ALHC is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

ALHC had negative earnings in the past year.
ALHC had a negative operating cash flow in the past year.

1.2 Ratios

ALHC has a Return On Assets of -20.46%. This is in the lower half of the industry: ALHC underperforms 75.22% of its industry peers.
Looking at the Return On Equity, with a value of -83.66%, ALHC is doing worse than 74.34% of the companies in the same industry.
Industry RankSector Rank
ROA -20.46%
ROE -83.66%
ROIC N/A
ROA(3y)-20.43%
ROA(5y)N/A
ROE(3y)-67.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ALHC's Gross Margin of 10.99% is on the low side compared to the rest of the industry. ALHC is outperformed by 78.76% of its industry peers.
In the last couple of years the Gross Margin of ALHC has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ALHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

ALHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALHC remains at a similar level compared to 1 year ago.
The debt/assets ratio for ALHC is higher compared to a year ago.

2.2 Solvency

ALHC has an Altman-Z score of 1.74. This is a bad value and indicates that ALHC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALHC (1.74) is comparable to the rest of the industry.
ALHC has a Debt/Equity ratio of 0.86. This is a neutral value indicating ALHC is somewhat dependend on debt financing.
ALHC has a Debt to Equity ratio of 0.86. This is in the lower half of the industry: ALHC underperforms 61.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACCN/A
WACC9.18%

2.3 Liquidity

A Current Ratio of 1.63 indicates that ALHC should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.63, ALHC is in the better half of the industry, outperforming 65.49% of the companies in the same industry.
ALHC has a Quick Ratio of 1.63. This is a normal value and indicates that ALHC is financially healthy and should not expect problems in meeting its short term obligations.
ALHC has a Quick ratio of 1.63. This is in the better half of the industry: ALHC outperforms 70.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.63

6

3. Growth

3.1 Past

The earnings per share for ALHC have decreased by -7.69% in the last year.
ALHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.50%.
The Revenue has been growing by 23.74% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q18.18%
Revenue 1Y (TTM)25.5%
Revenue growth 3Y23.74%
Revenue growth 5YN/A
Revenue growth Q2Q26.76%

3.2 Future

The Earnings Per Share is expected to grow by 13.27% on average over the next years. This is quite good.
Based on estimates for the next years, ALHC will show a very strong growth in Revenue. The Revenue will grow by 21.68% on average per year.
EPS Next Y11.7%
EPS Next 2Y20.25%
EPS Next 3Y18.78%
EPS Next 5Y13.27%
Revenue Next Year20.53%
Revenue Next 2Y20.99%
Revenue Next 3Y22.92%
Revenue Next 5Y21.68%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALHC. In the last year negative earnings were reported.
Also next year ALHC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ALHC's earnings are expected to grow with 18.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.25%
EPS Next 3Y18.78%

0

5. Dividend

5.1 Amount

No dividends for ALHC!.
Industry RankSector Rank
Dividend Yield N/A

ALIGNMENT HEALTHCARE INC

NASDAQ:ALHC (2/27/2024, 7:18:20 PM)

After market: 6.59 -0.33 (-4.77%)

6.92

+0.71 (+11.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.31B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.46%
ROE -83.66%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 10.99%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.23
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.63
Quick Ratio 1.63
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y11.7%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)25.5%
Revenue growth 3Y23.74%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y